Bobak R. Azamian
Chief Executive Officer, Tarsus Pharmaceuticals, Inc.
Companies
- Tarsus Pharmaceuticals, Inc.Chair Dec 16, 2022 to now1
- Tarsus Pharmaceuticals, Inc.Chief executive officer Oct 15, 2020 to now2
- Tarsus Pharmaceuticals, Inc.President Oct 15, 2020 to now2
- Tarsus Pharmaceuticals, Inc.Board member Oct 15, 2020 to Nov 18, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tarsus Pharmaceuticals, Inc. TARS861,412 shares3$60.0M at $69.64Sep 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 4, 2026Sold 2,900 shares at $91.27 of Tarsus Pharmaceuticals, Inc.3
- Sep 4, 2026Sold 7,100 shares at $90.27 of Tarsus Pharmaceuticals, Inc.3
- Sep 2, 2026Sold 10,000 shares at $80.06 of Tarsus Pharmaceuticals, Inc.4
- Jun 17, 2026Sold 5,418 shares at $61.81 of Tarsus Pharmaceuticals, Inc.5
- Jun 17, 2026Sold 4,582 shares at $61.24 of Tarsus Pharmaceuticals, Inc.5
- Mar 19, 2026Sold 11,964 shares at $67.00 of Tarsus Pharmaceuticals, Inc.6
- Mar 18, 2026Sold 11,667 shares at $68.71 of Tarsus Pharmaceuticals, Inc.6
- Mar 17, 2026Sold 10,972 shares at $69.42 of Tarsus Pharmaceuticals, Inc.6
- Mar 15, 2026Exercised options 66,274 shares of Tarsus Pharmaceuticals, Inc.7
- Dec 24, 2025Sold 557 shares at $83.54 of Tarsus Pharmaceuticals, Inc.8
- Dec 24, 2025Sold 5,443 shares at $82.41 of Tarsus Pharmaceuticals, Inc.8
- Dec 4, 2025Gift 51,885 shares of Tarsus Pharmaceuticals, Inc.9
- Sep 24, 2025Sold 6,000 shares at $55.37 of Tarsus Pharmaceuticals, Inc.10
- Aug 11, 2025Sold 6,000 shares at $50.00 of Tarsus Pharmaceuticals, Inc.11
- Mar 24, 2025Sold 6,000 shares at $50.00 of Tarsus Pharmaceuticals, Inc.12
- Mar 20, 2025Sold 8,534 shares at $50.11 of Tarsus Pharmaceuticals, Inc.13
- Mar 19, 2025Sold 8,551 shares at $47.40 of Tarsus Pharmaceuticals, Inc.13
- Mar 18, 2025Sold 7,131 shares at $46.29 of Tarsus Pharmaceuticals, Inc.13
- Mar 15, 2025Exercised options 51,395 shares of Tarsus Pharmaceuticals, Inc.14
- Mar 18, 2024Sold 10,415 shares at $30.60 of Tarsus Pharmaceuticals, Inc.15
- Mar 15, 2024Exercised options 28,274 shares of Tarsus Pharmaceuticals, Inc.15
- Dec 27, 2023Sold 8,000 shares at $20.22 of Tarsus Pharmaceuticals, Inc.16
- Dec 20, 2023Sold 30,557 shares at $20.36 of Tarsus Pharmaceuticals, Inc.17
- Dec 20, 2023Sold 9,443 shares at $19.96 of Tarsus Pharmaceuticals, Inc.17
- Nov 15, 2023Sold 200 shares at $19.28 of Tarsus Pharmaceuticals, Inc.18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARTarsus Pharmaceuticals, Inc., Chair
- 2
- 3
- 4SEC EDGARForm 4 filed Sep 3, 2026
- 5SEC EDGARForm 4 filed Jun 22, 2026
- 6SEC EDGARForm 4 filed Mar 19, 2026
- 7SEC EDGARForm 4 filed Mar 17, 2026
- 8SEC EDGARForm 4 filed Dec 30, 2025
- 9SEC EDGARForm 4 filed Dec 8, 2025
- 10SEC EDGARForm 4 filed Sep 26, 2025
- 11SEC EDGARForm 4 filed Aug 13, 2025
- 12SEC EDGARForm 4 filed Mar 26, 2025
- 13SEC EDGARForm 4 filed Mar 20, 2025
- 14SEC EDGARForm 4 filed Mar 18, 2025
- 15SEC EDGARForm 4 filed Mar 19, 2024
- 16SEC EDGARForm 4 filed Dec 29, 2023
- 17SEC EDGARForm 4 filed Dec 22, 2023
- 18SEC EDGARForm 4 filed Nov 17, 2023